Universal “Intravenous Solution (IV) Market” report examines the market position and viewpoint of the market globally, from various angles, such as key players, geological regions, types of product and application. And also cover the other information such as Intravenous Solution (IV) Market trends, Top players, chapter-wise Description followed by various user perceptions and Forecast till 2022.
Intravenous Solution (IV) Market – Scenario
The Market For Intravenous (IV) Solution Is Expected To Reach USD 11,511.2 Million By 2022 And Is Expected To Grow At A CAGR Of 7.69% During The Forecast Period 2016-2022. Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration.
Request for Sample Report at https://www.marketresearchfuture.com/sample_request/1235
These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.
Top Players:
ICU Medical,
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
And others.
Intravenous Solution Market – Segmentation:
Global IV Solutions Market has been segmented on the basis of types which comprises of Peripheral Parenteral Nutrition and Total Parenteral Nutrition.
On the basis of nutritional content which comprises of Amino acid solution, Carbohydrates, Vitamins & minerals, parenteral lipid emulsion and others.
On the basis of end users the global IV solutions market includes Hospital & Clinics, Ambulatory and Home Care.
Intravenous Solution Market – Regional Analysis:
The global market for IV Solutions is growing steadily. The market for IV Solutions is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 6,543.4 million by 2022. This is attributed to the factors such as Growing acceptance of vitamin C intravenous for Colorectal Cancer and increasing prevalence of the chronic diseases. Europe is the second largest market which is growing at a CAGR of 8.12% from 2016-2022. Asia-Pacific region is the fastest growing market for IV Solutions, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022.
Key Finding:
- The Global Intravenous (IV) Solution Market and is expected to reach USD 11,511.2 million by 2022
- By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016
- By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016
Major TOC of Intravenous (IV) Solution Market Research Report- Global Forecast to 2022:
1 REPORT PROLOGUE
2 INTRODUCTION
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
5 MARKET FACTOR ANALYSIS
6 GLOBAL IV SOLUTION MARKET, BY TYPES
7 GLOBAL IV SOLUTION MARKET, BY NUTRITIONAL CONTENT
8 GLOBAL IV SOLUTION MARKET, BY END USERS
9 GLOBAL IV SOLUTION MARKET, BY REGIONS
10 COMPANY SHARE ANALYSIS
11 COMPANY PROFILES
12 MRFR CONCLUSION
13 APPENDIX
14 List of Tables
15 List of Figure
Check Discount Here at https://www.marketresearchfuture.com/check-discount/1235
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Your information will never be shared with any third party.